To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

June 18, 2019___

Today's Rundown

Featured Story

Sanofi quits Voyager gene therapy deal once worth up to $845M

Sanofi is quitting two more programs it picked up in a 2015 pact with Voyager—a gene therapy for Huntington’s disease and one for Friedreich’s ataxia.

Top Stories

AstraZeneca spinout Viela bags $75M as FDA filing nears

AstraZeneca spinout Viela Bio has raised $75 million to take anti-CD19 antibody inebilizumab toward approval. The series B round comes 16 months after Viela broke free from AstraZeneca with six drugs and $250 million in funding.

VBI tanks after missing secondary goal in GSK head-to-head trial

VBI Vaccines’ hepatitis B candidate Sci-B-Vac has mostly matched GlaxoSmithKline’s Engerix-B in a phase 3 trial, but investors zeroed in on the failure to achieve a secondary objective and sent VBI’s stock down 66%.

J&J leads $7M round for German digital health co. Cara Care

Cara Care, a digital health startup focused on digestive diseases, raised $7 million to bring its mobile app to more patients, primarily in the U.S.

Reviving tired T cells to improve immuno-oncology treatments

A University of Pennsylvania team has discovered a protein that helps determine the fate of exhausted T cells—and that might be able to be targeted to improve immuno-oncology treatments.

Resources

[Whitepaper] Satisfying GxP Requirements Using the Internet of Things (IoT)

How can the Internet of Things (IoT) enable you to meet GxP?

[Whitepaper] Managing Comorbidities in Type 2 Diabetes – Real World Evidence for Change

Patients living with diabetes deserve better – Real-World Evidence for effecting/realizing change in the management of type 2 diabetes and cardiovascular/renal comorbidities.

[Webinar] Why do US sponsors come to Russia? New options for clinical trials.

Fast and cost-efficient patient-enrollment,100% success strategy for obtaining a CTA, unified market authorization across the EEU countries. Find out the key compelling reasons to conduct studies in Russia.

[Whitepaper] Agile Competitive Intelligence Strategies For Healthcare

What is agile competitive intelligence, and how can it help take market research to the next level?

[POCKET GUIDE] Reference and Literature Management Made Easy

Get 5 quick tips for faster research and better results!

[Report] Precision medicine from concept to clinic

In this publication, Blue Latitude Health maps the journey of stakeholders impacted by the rise of precision medicine today. Download the report.

[Whitepaper] Flow Chemistry: A Scale-Up Solution for Modern API Development & Manufacturing

Increase Safety & Flexibility with Flow Chemistry

[On-Demand Webinar] Lessons Learned Implementing an End-to-End RIM Solution

IONIS shares best practices for implementing an end-to-end RIM solution in this on-demand webinar. Watch now.

[Whitepaper] Site-specific, Patient-centered and Whip-smart: Enrollment Assistants Adapt to a Shifting Landscape

Increasingly complex clinical trials place a tremendous burden on study sites, exacerbating already-troubling recruitment and enrollment issues. Overwhelmed, many sites may not be up to the task or have the appropriate infrastructure, creating costly delays that keep new therapies from patients.

[Case Study] Clinical Supply Management

Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study.

[Video] Demand Led Services and Clinical Supply Efficiency

Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels.

[eBook] Strategies for Efficient Clinical Supply Management and Forecasting

Download the eBook to explore a proactive approach for clinical supply management.

Events